Vimarsana
Biggest News Aggregation in the World

Page 29 - Compass Pathways News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compass Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compass Pathways Today - Breaking & Trending Today

Psilocybin May Help Some Who Battle Anorexia - Vimarsana News

Psilocybin May Help Some Who Battle Anorexia

TUESDAY, Aug. 1, 2023 (HealthDay News) -- One dose of the hallucinogenic ingredient in "magic mushrooms" may help some people with anorexia move past their preoccupation with body image, an

COMPASS Pathways plc (NASDAQ:CMPS) Short Interest Update - Vimarsana News

COMPASS Pathways plc (NASDAQ:CMPS) Short Interest Update

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) was the recipient of a significant increase in short interest in the month of July. As of July 15th, there was short interest totalling 3,460,000 shares, an increase of 44.2% from the June 30th total of 2,400,000 shares. Based on an average daily trading volume, of 286,200 […]

This Unexpected Development Is Yet Another Green Flag for Compass Pathways Stock - Vimarsana News

This Unexpected Development Is Yet Another Green Flag for Compass Pathways Stock

For biotechs developing psychedelic therapies, good news comes in many forms.

Source: fool.com
Related Topics:
Compass Pathways
Psilocybin for Anorexia Shows Promise in Early Trial - Vimarsana News

Psilocybin for Anorexia Shows Promise in Early Trial

10-woman study found the psychoactive compound to be safe, positively perceived

A single pill made using magic mushroom hallucinogen could help treat anorexia that affects 100,000 Britons, study suggests - Vimarsana News

A single pill made using magic mushroom hallucinogen could help treat anorexia that affects 100,000 Britons, study suggests

If successful, they could herald a new era for treating anorexia, which has the highest mortality rate of any psychiatric condition (more than 5 per cent, reported JAMA Psychiatry in 2011).